Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 0.72
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Amerise Biosciences Ltd. engages in the manufacture of plastic products. It does not have any current business activity. The company was founded on August 27, 1984 and is headquartered in Ahmedabad, India.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI
Data is available to registered users only
Buy
Sell